The phosphatidylinositol 3-kinase (PI3K) pathway in acute myeloid leukemia and inhibition of mechanistic target of rapamycin (mTOR) as a therapeutic target
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F20%3A00013030" target="_blank" >RIV/00023736:_____/20:00013030 - isvavai.cz</a>
Result on the web
<a href="https://novapublishers.com/shop/hematologic-malignancies-an-overview/" target="_blank" >https://novapublishers.com/shop/hematologic-malignancies-an-overview/</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
The phosphatidylinositol 3-kinase (PI3K) pathway in acute myeloid leukemia and inhibition of mechanistic target of rapamycin (mTOR) as a therapeutic target
Original language description
Acute myeloid leukemia is a heterogenous complex malignancy characterized by proliferating myeloblasts in the bone marrow and a diverse range of recurrent molecular aberrations that occur in many different combination.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Hematological malignancies: an overview
ISBN
978-1-53618-124-1
Number of pages of the result
41
Pages from-to
47-87
Number of pages of the book
338
Publisher name
Nova Science
Place of publication
New York
UT code for WoS chapter
—